Dr. Dichek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1959 Ne Pacific St
# C212
Seattle, WA 98195Phone+1 206-685-6959- Is this information wrong?
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 1984 - 1987
- David Geffen School of Medicine at UCLAClass of 1984
- Massachusetts General HospitalFellowship, Cardiovascular Disease
Certifications & Licensure
- CA State Medical License 1995 - Present
- WA State Medical License 2001 - 2026
- MA State Medical License 1986 - 2001
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
Publications & Presentations
PubMed
- Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies.Parveen K Garg, Harpreet S Bhatia, Tara S Allen, Tabitha Grainger, Anna L Pouncey, David Dichek, Renu Virmani, Jonathan Golledge, Matthew A Allison, Janet T Powell> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 2024 Jan 1
- Apolipoprotein A-I vascular gene therapy reduces vein-graft atherosclerosis.Lianxiang Bi, Bradley K Wacker, Kaushik Komandur, Nicole Sanford, David A Dichek> ;Molecular Therapy. Methods & Clinical Development. 2023 Sep 14
- N-terminal eGFP-tagging of rabbit apolipoprotein A-I decreases expression and impairs cholesterol-efflux activity.Bradley K Wacker, Lianxiang Bi, Li Liu, Mary G Sorci-Thomas, Philip Ng, Donna J Palmer, Chongren Tang, David A Dichek> ;Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids. 2023 May 1
- Join now to see all
Press Mentions
- Baby Born with Severe Muscular Disease Shows Progress After Taking Experimental Drug at Seattle Children’s HospitalJune 1st, 2019
Grant Support
- A Proteomic Approach For Understanding Plaque RuptureNational Heart, Lung, And Blood Institute2012
- Cardiovascular Research Training ProgramNational Heart, Lung, And Blood Institute2002–2011
- Engineering Blood Vessels To Resist AtherosclerosisNational Heart, Lung, And Blood Institute2006–2009
- Mechanisms Of Urokinase-Induced Vascular DiseaseNational Heart, Lung, And Blood Institute2005–2009
- Transforming Growth Factor Betal And Arterial DiseaseNational Heart, Lung, And Blood Institute2001–2005
- Genetic Engineering Of Vascular TissueNational Heart, Lung, And Blood Institute2000–2002
- Genetic Engineering Of Vascular TissueNational Heart, Lung, And Blood Institute1998–2000
- Gene Transfer Approaches To Vascular Graft DiseaseNational Heart, Lung, And Blood Institute1998
Other Languages
- French
Hospital Affiliations
- UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: